Jasper Therapeutics appoints COO Jeet Mahal as CEO; Ron Martell steps down, Thomas Wiggans named Executive Chair

Jasper Therapeutics, Inc.

Effective Jan 5, 2026, Jeet Mahal becomes CEO and President; he also joins the Board as Class III director.
Outgoing CEO Ron Martell's departure is without cause; he receives 18 months base salary plus COBRA for up to 18 months.
Thomas Wiggans, current Board Chair, appointed Executive Chair effective Jan 5, 2026.
Mahal's annual salary increased to $600,000 with eligibility for performance bonus up to 50% of base salary.
Company to host investor webinar on Jan 8, 2026 to present updated data from BEACON study and open-label extension in CSU/CIndU.

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001213900-26-002185
form_type: 8-K
ticker: JSPR
cik: 0001788028
company_name: Jasper Therapeutics, Inc.
filed_at: 2026-01-07T23:59:59+00:00
discovered_at: 2026-05-14T18:02:36.185576+00:00
generated_at: 2026-05-16T11:23:39.767774+00:00
sec_items: ["5.02", "8.01", "9.01"]
event_type: leadership
sentiment: neutral
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001213900-26-002185
json_url: https://secwatch.observer/filing/0001213900-26-002185.json
markdown_url: https://secwatch.observer/filing/0001213900-26-002185.md
text_url: https://secwatch.observer/filing/0001213900-26-002185.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1788028/000121390026002185/0001213900-26-002185-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1788028/000121390026002185/ea0271735-8k_jasper.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

GRAIL appoints Joshua Ofman as CEO with amended compensation and severance

GRAIL, Inc. June 1, 2026, 4:07 PM ET leadership Items 5.02, 8.01, 9.01

same SEC item: 5.02, 8.01, 9.01 same event type: leadership similar materiality

AIxCrypto Holdings announces executive resignations, appointments, and wind-down of biotech segment

AIxCrypto Holdings, Inc. May 28, 2026, 5:23 PM ET leadership Items 5.02, 8.01, 9.01

same SEC item: 5.02, 8.01, 9.01 same event type: leadership similar materiality

ARQ

Arq appoints Shimon Steinmetz as CFO, CAO Stacia Hansen resigns

Arq, Inc. May 27, 2026, 4:32 PM ET leadership Items 5.02, 8.01, 9.01

same SEC item: 5.02, 8.01, 9.01 same event type: leadership similar materiality

CorVel CEO Michael Combs to become Executive Chair; Sarah Scott appointed CEO and President effective July 1, 2026

CORVEL CORP June 1, 2026, 5:05 PM ET leadership Items 5.02, 7.01, 9.01